58 / 61
Nintedanib/docetaxel efficacy in advanced lung adenocarcinoma treated with
1L chemotherapy / 2L immunotherapy in nintedanib NPU program
Poster presented at the IASLC 18th World Conference on Lung Cancer (IASLC WCLC 2017), October 15–18, 2017, Yokohama, Japan